Target expression details
Target General Information | |||||
---|---|---|---|---|---|
Target ID | T81100 | ||||
Target Name | mRNA of SLGT2 | ||||
Synonyms | mRNA of Low affinity sodium-glucose cotransporter; mRNA of Na(+)/glucose cotransporter 2; mRNA of SGLT2; mRNA of SLC5A2; mRNA of Sodium/glucosecotransporter 2; mRNA of Solute carrierfamily 5 member 2; SLC5A2 | ||||
Target Type | Clinical Trial | ||||
Gene Name | SLC5A2 | ||||
Biochemical Class | Solute:sodium symporter | ||||
UniProt ID | SC5A2_HUMAN | ||||
Target Gene Expression Profiles in the Disease-Relevant Drug Targeted Tissue of the Patients and Healthy Individuals | |||||
Disease | Type 2 diabetes | ||||
Example drug | ISIS-SGLT2 | Phase 1 | [551052], [1572592] | ||
Tissue | Liver tissue | ||||
Level of differential expression between the patients in the disease section of the tissue and the tissues of healthy individual | Fold-change: -0.09 Z-score: -0.37 P-value: 3.26E-01 |
||||
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles in the tissue of healthy individual
|
|||||
Target Gene Expression Profiles in Other Tissues of Healthy Individuals | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.